Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 3, 2022

View Archived Issues

Tyrosine kinase inhibitor NTRC-0652-0 shows promise for the treatment of cholangiocarcinoma

New prolyl endopeptidase inhibitors identified at Accure Therapeutics

ReViral describes new compounds for respiratory syncytial virus infections

Mcl-1 inhibitors discovered at Janssen

3M Innovative Properties divulges new Toll-like receptor 7 agonists

Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical patent Bcl-2 and/or Bcl-X inhibitors

Endothelial BCAR1 expression associated with antiangiogenic therapy resistance

Discovery of novel MBL inhibitors as promising beta-lactam antibiotics

Epigenetic-mediated immune mechanisms identified in TB

A microbiota-macrophage-iron axis regulates hematopoietic stem cell fate decisions under stress

A comprehensive catalog of functional cell types and cellular states in human brain metastases

Targeting PPARalpha-ACOT12 axis as a potential new therapeutic strategy for osteoarthritis

PLA2-IIA modulates immunity through its interaction with microbiota

CIRM grant supports Juvena's preclinical work on JUV-161 for myotonic dystrophy type 1

Brickell licenses rights to Carna's STING antagonists for autoimmune and inflammatory diseases

Anakuria's AT-20494 to be studied for ADPKD and other indications

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...